Cargando…
Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review
BACKGROUND: Ectopic adrenocorticotropic hormone (ACTH) syndrome (EAS) is caused by tumours releasing ACTH. Ectopic ACTH-producing tumour regression is rarely induced using steroidogenesis inhibitors. We presented a case of EAS in which ACTH production by a lung tumour was reduced by metyrapone (MTP)...
Autores principales: | Iwayama, Hideyuki, Hirase, Sho, Nomura, Yuka, Ito, Tatsuo, Morita, Hiroyuki, Otake, Kazuo, Okumura, Akihisa, Takagi, Junko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872391/ https://www.ncbi.nlm.nih.gov/pubmed/29587720 http://dx.doi.org/10.1186/s12902-018-0246-2 |
Ejemplares similares
-
A Rapidly Progressive Case of Ectopic Adrenocorticotropic Hormone (ACTH) Syndrome
por: Raj, Rishi, et al.
Publicado: (2021) -
Evaluation of plasma ACTH in the metyrapone test is insufficient for the diagnosis of secondary adrenal insufficiency
por: Papierska, Lucyna, et al.
Publicado: (2022) -
Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel
por: Bomback, Andrew S, et al.
Publicado: (2011) -
Therapeutic Effects of Adrenocorticotropic Hormone ACTH in Children with Severely Intractable Seizure
por: NASIRI, Jafar, et al.
Publicado: (2017) -
A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency
por: Sato, Yozo, et al.
Publicado: (2019)